Strategy

Aesica has an ambitious growth strategy. We intend to build on our leading position in the supply of Active Pharmaceutical Ingredients (APIs) through the acquisition of products and facilities, and through growing our custom synthesis business.

We have a well-balanced model with strong revenue streams from API sales and a great potential for expanding our custom synthesis business through co-development projects and risk sharing with our clients.